GNH India Pharmaceuticals Limited — Lenvatinib Exporter Profile
Indian Pharmaceutical Exporter · #5 for Lenvatinib · $65.7K export value · DGFT Verified
GNH India Pharmaceuticals Limited is the #5 Indian exporter of Lenvatinib with $65.7K in export value and 20 verified shipments. GNH India Pharmaceuticals Limited holds a 3.1% market share in Lenvatinib exports across 2 countries. The company exports 11 pharmaceutical products worth $1.8M across 3 therapeutic categories.
GNH India Pharmaceuticals Limited — Lenvatinib Export Profile: Buyers & Destinations
Where Does GNH India Pharmaceuticals Limited Export Lenvatinib?
| Country | Value | Shipments | Share |
|---|---|---|---|
| SPAIN | $64.4K | 19 | 98.0% |
| NETHERLANDS | $1.3K | 1 | 2.0% |
GNH India Pharmaceuticals Limited exports Lenvatinib to 2 countries. The largest destination is SPAIN accounting for 98.0% of GNH India Pharmaceuticals Limited's Lenvatinib shipments. These destinations reflect GNH India Pharmaceuticals Limited's established distribution network and regulatory approvals in key markets.
Who Are the Top Buyers of Lenvatinib from GNH India Pharmaceuticals Limited?
| Buyer | Country | Value | Orders |
|---|---|---|---|
| TO THE ORDER, | SPAIN | $39.7K | 11 |
| TO THE ORDER | SPAIN | $24.7K | 8 |
| BURG HOEBERSSTRAAT 23 | NETHERLANDS | $1.3K | 1 |
GNH India Pharmaceuticals Limited supplies Lenvatinib to 3 buyers globally. The largest buyer is TO THE ORDER, (SPAIN), followed by TO THE ORDER (SPAIN) and BURG HOEBERSSTRAAT 23 (NETHERLANDS). These buyers represent pharmaceutical distributors, hospital groups, and government procurement agencies in their respective markets.
What Is India's Total Lenvatinib Export Value and How Much Does GNH India Pharmaceuticals Limited Contribute?
India exported $1.1M worth of Lenvatinib through 863 shipments from 127 suppliers to 74 countries, serving 242 buyers globally. GNH India Pharmaceuticals Limited contributes $65.7K to this total, accounting for 3.1% of India's Lenvatinib exports. GNH India Pharmaceuticals Limited ships Lenvatinib to 2 countries through 3 buyers.
What Is the Average Shipment Value for GNH India Pharmaceuticals Limited's Lenvatinib Exports?
GNH India Pharmaceuticals Limited's average Lenvatinib shipment value is $3.3K per consignment, based on 20 shipments totaling $65.7K. The largest destination is SPAIN (98.0% of GNH India Pharmaceuticals Limited's Lenvatinib exports).
How Does GNH India Pharmaceuticals Limited Compare to Other Indian Lenvatinib Exporters?
GNH India Pharmaceuticals Limited ranks #5 among 127 Indian Lenvatinib exporters with a 3.1% market share. The top 3 exporters are SANDOZ PRIVATE LIMITED ($316.5K), SUN PHARMACEUTICAL INDUSTRIES LIMITED ($250.0K), PROSPERA LIFE SCIENCES PRIVATE LIMITED ($115.1K). GNH India Pharmaceuticals Limited processed 20 shipments to 2 destination countries.
What Lenvatinib Formulations Does GNH India Pharmaceuticals Limited Export?
| Product Description / Formulation | Value | Shipments |
|---|---|---|
| LENVIMA 10MG LENVATINIB CAPSULES /10MG ( | $32.0K | 5 |
| LENVIMA 10MG LENVATINIB CAPSULES /10MG | $17.8K | 3 |
| LENVIMA 4MG LENVATINIB CAPSULES /4MG (MF | $7.7K | 6 |
| LENVIMA 4MG LENVATINIB CAPSULES /4MG MF | $6.9K | 5 |
| LENTRIS 10MG LENVATINIB/ 10MG, BRAND NAM | $1.3K | 1 |
GNH India Pharmaceuticals Limited exports 5 distinct Lenvatinib formulations including tablets, capsules, syrups, and combination drugs. The top formulation is LENVIMA 10MG LENVATINIB CAPSULES /10MG ( with 5 shipments worth $32.0K.
How Does GNH India Pharmaceuticals Limited Compare to Nearest Lenvatinib Exporters?
Exporters ranked immediately above and below #5 by export value
| # | Supplier | Export Value | Shipments | Countries | Avg/Shipment |
|---|---|---|---|---|---|
| 3 | PROSPERA LIFE SCIENCES PRIVATE LIMITED | $115.1K | 42 | 4 | $2.7K |
| 4 | BDR PHARMACEUTICALS INTERNATIONAL PRIVATE LIMITED | $98.6K | 21 | 4 | $4.7K |
| 5 | GNH INDIA PHARMACEUTICALS LIMITED ★ | $65.7K | 20 | 2 | $3.3K |
| 6 | KARDI TRADING PRIVATE LIMITED | $65.1K | 6 | 2 | $10.9K |
| 7 | KINGS GLOBAL BIOTECH LIMITED | $52.2K | 12 | 1 | $4.3K |
GNH India Pharmaceuticals Limited ranks #5 among 127 Indian Lenvatinib exporters. Average shipment value of $3.3K compared to the market average of $8.8K. The closest competitors by value are PROSPERA LIFE SCIENCES PRIVATE LIMITED and BDR PHARMACEUTICALS INTERNATIONAL PRIVATE LIMITED.
Which Indian Ports Ship Lenvatinib Exports?
| Port | Shipments | % Share |
|---|---|---|
| SAHAR AIR CARGO ACC (INBOM4) | 250 | 29.0% |
| SAHAR AIR | 200 | 23.2% |
| DELHI AIR CARGO ACC (INDEL4) | 76 | 8.8% |
| DELHI AIR | 72 | 8.3% |
| Bombay Air | 62 | 7.2% |
| Bombay Air Cargo | 30 | 3.5% |
| AHEMDABAD AIR | 22 | 2.5% |
| HYDERABAD ACC (INHYD4) | 18 | 2.1% |
What Other Advanced Oncology Products Does GNH India Pharmaceuticals Limited Export?
GNH India Pharmaceuticals Limited also exports these advanced oncology products. Each links to the detailed product page.
About GNH India Pharmaceuticals Limited
GNH India Pharmaceuticals Limited exports 11 products worth $1.8M. Beyond Lenvatinib, top products include Immunoglobulin, Pembrolizumab, Ustekinumab, Pazopanib, Actinomycin. View the complete GNH India Pharmaceuticals Limited profile for full portfolio analysis.
Market Intelligence
Latest developments and market context
Detailed market intelligence for Lenvatinib — including regulatory updates, trade policy changes, and competitive landscape analysis — will be available in an upcoming update. This section will feature AI-researched insights from verified industry sources, government notifications, and market reports.
Official References & Regulatory Resources
- CDSCO India
- Pharmexcil
- IBEF — India Pharma Industry
- Ministry of Commerce — Pharma Exports
- India Trade Statistics (DGFT)
Verify manufacturer licensing and export certifications with the official agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Product Matching: Lenvatinib shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature.
- 2.Supplier Identification: GNH India Pharmaceuticals Limited matched across shipments using name normalization, accounting for company name formatting variations.
- 3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort company rankings.
- 4.Verified Records: This page is backed by 20 individual customs records matching GNH India Pharmaceuticals Limited exporting Lenvatinib, covering 5 formulations to 2 countries via 3 buyers.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
Global Coverage
Exports to 74+ countries, 242+ buyers
Expert-Reviewed
Analyzed by pharmaceutical trade specialists
Get Lenvatinib Export Data from GNH India Pharmaceuticals Limited
Access shipment-level details, pricing data, buyer connections, and competitive analysis for GNH India Pharmaceuticals Limited's Lenvatinib exports. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.
GNH India Pharmaceuticals Limited
Full Company Profile →
11 products · $1.8M total trade · 3 categories
Lenvatinib Stats
Company Overview
Top Products by GNH India Pharmaceuticals Limited
Related Analysis
Need Detailed Export Data?
Access shipment-level records, pricing trends, and buyer contacts for GNH India Pharmaceuticals Limited.
Request DemoView Pricing →Data Source
Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports for Lenvatinib. For current shipment-level data, contact TransData Nexus.